LJI Research Assistant Professor Cecilia Lindestam Arlehamn, Ph.D., investigates how the immune system’s T cells may contribute to Parkinson’s disease, Alzheimer’s disease, ALS, and even long COVID. Her research has revealed how T cells can target vulnerable neurons in patients with Parkinson’s disease, potentially driving disease onset. Her recent work centers on the question: Could inflammatory T cells lead to ALS and long COVID symptoms as well? Dr. Lindestam Arlehamn will share her findings so far and the next steps in her quest to help patients with these diseases.
Upcoming

A new window into disease risk
LJI Assistant Professor Dr. Tal Einav harnesses computational biology and physics to study how the body fights disease. His research sheds light on how different groups – women and men, children and seniors – combat viral infections, cancers, and much more. Dr. Einav will share how leveraging models and algorithms can help us design better vaccines and accelerate the field of personalized medicine.